title: Interleukin-18 promoter polymorphism and asthma risk: a meta-analysis.
abstract: Some studies have shown that IL-18 was associated with aetiology and progression of asthma. However, the association between single-nucleotide polymorphisms -607C/A (rs1946518) and -137G/C (rs187238) located in the IL-18 gene promoter and asthma risk was still controversial and ambiguous. To derive a more precise effect on the association between these polymorphisms and asthma risk, we performed a meta-analysis based on the currently available evidence of the literature. A total of 5 studies with 1411 cases and 1525 controls for -607C/A polymorphism and 5 studies with 1883 cases and 6645 controls for -137G/C polymorphism were identified to perform a meta-analysis, up to October 2010. Summary ORs and corresponding 95% CIs for IL-18 polymorphisms and asthma were estimated using fixed- and random-effects models when appropriate. Heterogeneity and publication bias were evaluated. We found that individuals carrying AC/CC genotype of -607C/A polymorphism were associated with an increased asthma risk in recessive model (OR = 1.278; 95% CI, 1.073-1.522). However, no significant association was observed between -137G/C polymorphism and asthma risk under different contrast models. There was no evidence of publication bias. The present meta-analysis suggested that IL-18 -607C/A polymorphism in promoter region was associated with asthma risk.
authors: Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, People's Republic of China.
authors: Ying
authors: Y
authors: Ma
authors: Bo
authors: B
authors: Zhang
authors: Ren-Kuan
authors: RK
authors: Tang
authors: Yun
authors: Y
authors: Liu
authors: Guo-Guang
authors: GG
authors: Peng
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: Clin Exp Allergy. 2003 Aug;33(8):1023-5
references: 12911773
references: Clin Exp Allergy. 2006 Feb;36(2):211-8
references: 16433859
references: Mol Cell Biochem. 2000 Sep;212(1-2):5-9
references: 11108130
references: Nat Rev Immunol. 2008 Mar;8(3):169-82
references: 18301422
references: Eur J Immunol. 2000 Apr;30(4):1113-9
references: 10760800
references: Genomics. 1998 Jul 1;51(1):161-3
references: 9693051
references: Tissue Antigens. 2007 Oct;70(4):314-8
references: 17767553
references: Nat Immunol. 2000 Aug;1(2):132-7
references: 11248805
references: J Clin Lab Anal. 2008;22(1):39-44
references: 18200581
references: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references: 13655060
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: Mol Biol Rep. 2011 Jan;38(1):379-85
references: 20424918
references: Exp Dermatol. 2009 Jul;18(7):628-33
references: 19469892
references: Clin Exp Immunol. 2001 Aug;125(2):177-83
references: 11529906
references: Allergy. 2004 Aug;59(8):845-9
references: 15230817
references: J Immunol. 2000 Mar 1;164(5):2701-10
references: 10679111
references: J Allergy Clin Immunol. 2003 Jan;111(1):117-22
references: 12532106
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: J Immunol. 1999 May 1;162(9):5070-7
references: 10227975
references: J Allergy Clin Immunol. 2006 Feb;117(2):269-74
references: 16461126
references: Allergy. 2005 Jul;60(7):900-6
references: 15932380
references: J Immunol. 2001 Jan 15;166(2):945-51
references: 11145671
references: J Allergy Clin Immunol. 2002 Mar;109(3):498-506
references: 11897998
references: Am J Respir Crit Care Med. 2009 Dec 1;180(11):1048-55
references: 19745201
references: J Neuroimmunol. 2001 Jan 1;112(1-2):146-52
references: 11108943
references: Int J Immunogenet. 2008 Feb;35(1):63-8
references: 18093181
references: J Allergy Clin Immunol. 2001 Feb;107(2):331-6
references: 11174201
references: BMJ. 2003 Sep 6;327(7414):557-60
references: 12958120